191 related articles for article (PubMed ID: 11561095)
1. Calcilytic compounds: potent and selective Ca2+ receptor antagonists that stimulate secretion of parathyroid hormone.
Nemeth EF; Delmar EG; Heaton WL; Miller MA; Lambert LD; Conklin RL; Gowen M; Gleason JG; Bhatnagar PK; Fox J
J Pharmacol Exp Ther; 2001 Oct; 299(1):323-31. PubMed ID: 11561095
[TBL] [Abstract][Full Text] [Related]
2. Calcimimetics with potent and selective activity on the parathyroid calcium receptor.
Nemeth EF; Steffey ME; Hammerland LG; Hung BC; Van Wagenen BC; DelMar EG; Balandrin MF
Proc Natl Acad Sci U S A; 1998 Mar; 95(7):4040-5. PubMed ID: 9520489
[TBL] [Abstract][Full Text] [Related]
3. Effects of endothelin-1 on Ca2+ signaling and secretion in parathyroid cells.
Fujii Y; Tomić M; Stojilković SS; Iida T; Brandi ML; Ogino Y; Sakaguchi K
J Bone Miner Res; 1995 May; 10(5):716-25. PubMed ID: 7639107
[TBL] [Abstract][Full Text] [Related]
4. Pharmacodynamics of the type II calcimimetic compound cinacalcet HCl.
Nemeth EF; Heaton WH; Miller M; Fox J; Balandrin MF; Van Wagenen BC; Colloton M; Karbon W; Scherrer J; Shatzen E; Rishton G; Scully S; Qi M; Harris R; Lacey D; Martin D
J Pharmacol Exp Ther; 2004 Feb; 308(2):627-35. PubMed ID: 14593085
[TBL] [Abstract][Full Text] [Related]
5. Hypertensive effect of calcilytic NPS 2143 administration in rats.
Rybczynska A; Lehmann A; Jurska-Jasko A; Boblewski K; Orlewska C; Foks H; Drewnowska K
J Endocrinol; 2006 Oct; 191(1):189-95. PubMed ID: 17065402
[TBL] [Abstract][Full Text] [Related]
6. Ca2+-induced increases in steady-state concentrations of intracellular calcium are not required for inhibition of parathyroid hormone secretion.
Russell J; Zhao W; Christ G; Ashok S; Angeletti RH
Mol Cell Biol Res Commun; 1999 Jun; 1(3):221-6. PubMed ID: 10425230
[TBL] [Abstract][Full Text] [Related]
7. Thimerosal increases the responsiveness of the calcium receptor in human parathyroid and rMTC6-23 cells.
Mihai R; Lai T; Schofield G; Farndon JR
Cell Calcium; 1999; 26(3-4):95-101. PubMed ID: 10598273
[TBL] [Abstract][Full Text] [Related]
8. Calcimimetic compound NPS R-568 stimulates calcitonin secretion but selectively targets parathyroid gland Ca(2+) receptor in rats.
Fox J; Lowe SH; Conklin RL; Petty BA; Nemeth EF
J Pharmacol Exp Ther; 1999 Aug; 290(2):480-6. PubMed ID: 10411553
[TBL] [Abstract][Full Text] [Related]
9. NPS R-568: a type II calcimimetic compound that acts on parathyroid cell calcium receptor of rats to reduce plasma levels of parathyroid hormone and calcium.
Fox J; Lowe SH; Petty BA; Nemeth EF
J Pharmacol Exp Ther; 1999 Aug; 290(2):473-9. PubMed ID: 10411552
[TBL] [Abstract][Full Text] [Related]
10. An orally active calcium-sensing receptor antagonist that transiently increases plasma concentrations of PTH and stimulates bone formation.
Kumar S; Matheny CJ; Hoffman SJ; Marquis RW; Schultz M; Liang X; Vasko JA; Stroup GB; Vaden VR; Haley H; Fox J; DelMar EG; Nemeth EF; Lago AM; Callahan JF; Bhatnagar P; Huffman WF; Gowen M; Yi B; Danoff TM; Fitzpatrick LA
Bone; 2010 Feb; 46(2):534-42. PubMed ID: 19786130
[TBL] [Abstract][Full Text] [Related]
11. The search for calcium receptor antagonists (calcilytics).
Nemeth EF
J Mol Endocrinol; 2002 Aug; 29(1):15-21. PubMed ID: 12200226
[TBL] [Abstract][Full Text] [Related]
12. Interaction between extracellular calcium and endothelin-1 influences parathyroid hormone secretion from bovine parathyroid cells through the increase in intracellular calcium.
Chang JM; Lai YH; Tsai JH
Miner Electrolyte Metab; 1997; 23(2):113-20. PubMed ID: 9252978
[TBL] [Abstract][Full Text] [Related]
13. Parathyroid hormone 7-84 induces hypocalcemia and inhibits the parathyroid hormone 1-84 secretory response to hypocalcemia in rats with intact parathyroid glands.
Huan J; Olgaard K; Nielsen LB; Lewin E
J Am Soc Nephrol; 2006 Jul; 17(7):1923-30. PubMed ID: 16707565
[TBL] [Abstract][Full Text] [Related]
14. Antagonizing the parathyroid calcium receptor stimulates parathyroid hormone secretion and bone formation in osteopenic rats.
Gowen M; Stroup GB; Dodds RA; James IE; Votta BJ; Smith BR; Bhatnagar PK; Lago AM; Callahan JF; DelMar EG; Miller MA; Nemeth EF; Fox J
J Clin Invest; 2000 Jun; 105(11):1595-604. PubMed ID: 10841518
[TBL] [Abstract][Full Text] [Related]
15. Calcimimetic and calcilytic drugs: just for parathyroid cells?
Nemeth EF
Cell Calcium; 2004 Mar; 35(3):283-9. PubMed ID: 15200152
[TBL] [Abstract][Full Text] [Related]
16. Fluoride interactions with stimulus-secretion coupling of normal and pathological parathyroid cells.
Ridefelt P; Hellman P; Rastad J; Larsson R; Akerström G; Gylfe E
Acta Physiol Scand; 1992 Jul; 145(3):275-85. PubMed ID: 1325732
[TBL] [Abstract][Full Text] [Related]
17. A novel calcium-sensing receptor antagonist transiently stimulates parathyroid hormone secretion in vivo.
Arey BJ; Seethala R; Ma Z; Fura A; Morin J; Swartz J; Vyas V; Yang W; Dickson JK; Feyen JH
Endocrinology; 2005 Apr; 146(4):2015-22. PubMed ID: 15637285
[TBL] [Abstract][Full Text] [Related]
18. Allosteric activation of the Ca2+ receptor expressed in Xenopus laevis oocytes by NPS 467 or NPS 568.
Hammerland LG; Garrett JE; Hung BC; Levinthal C; Nemeth EF
Mol Pharmacol; 1998 Jun; 53(6):1083-8. PubMed ID: 9614212
[TBL] [Abstract][Full Text] [Related]
19. Regions in rat and human parathyroid hormone (PTH) 2 receptors controlling receptor interaction with PTH and with antagonist ligands.
Goold CP; Usdin TB; Hoare SR
J Pharmacol Exp Ther; 2001 Nov; 299(2):678-90. PubMed ID: 11602681
[TBL] [Abstract][Full Text] [Related]
20. A flickery block of a K+ channel mediated by extracellular Ca2+ and other agonists of the Ca2+-sensing receptors in dispersed bovine parathyroid cells.
Vassilev PM; Kanazirska MP; Ye C; Francis J; Hong K; Brown EM
Biochem Biophys Res Commun; 1997 Jan; 230(3):616-23. PubMed ID: 9015373
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
